Analysis And Perspectives

Polycythemia vera treatment market is expected to substantially change and it will be dominated by approved products, JAKAFI and BESREMi.

Next-Generation Sequencing (NGS) or commonly referred to as deep sequencing or massively parallel sequencing, is an important field of sequencing technology applied to determine the RNA or DNA sequence. It aims to provide detailed information about the genetic variation in organisms, diseases, or other biological p...

Future of MRD testing looks promising, as ultra-sensitive MRD testing methods have already proven useful in numerous clinical studies.

Oncology drugs pipeline is also looking promising, with potential candidates such as Lynparza, Trodelvy, Glofitamab, Epcoritamab, and others.

The Protein Supplements Market is rising owing to growing demand among fitness enthusiasts. Companies are developing protein products to cater different needs

Donanemab is a promising new Alzheimer’s disease treatment. Donanemab has the potential to rule the Alzheimer’s disease market.

Absence of approved drugs for EBV treatment offers many opportunities for pharma companies to take advantage of an untapped EBV market.

Pacemakers Market is growing at an immense pace. Major development has been registered in the market. Several MedTech Companies are developing Pacemakers

Development of disease-specific therapies for primary biliary cholangitis treatment will auger well for market landscape in coming years.

Biologics are emerging as a potential option in the Nasal Polyposis Treatment Market. Several pharma companies are working in the space.